T1	Participants 182 229	trauma patients requiring abdominal exploration
T2	Participants 347 410	Patients were randomly assigned to one of two treatment groups.
T3	Participants 517 626	Five hundred ninety-two patients were evaluated: 283 received ampicillin/sulbactam and 309 received cefoxitin
T4	Participants 671 700	ampicillin/sulbactam patients
T5	Participants 718 736	cefoxitin patients
T6	Participants 764 816	cefoxitin patients with colon injuries were analyzed
T7	Participants 935 961	cefoxitin-treated patients
